logo-loader
Energy
Empyrean Energy PLC

Empyrean Energy: Gas production starts at Dempsey well

"This is a milestone achievement and with production and gas sales now underway at Dempsey 1-15 crucial data on the quality of the reservoir will now be collated ahead of fracture stimulating this zone”

oil and gas operations
Works are underway to advance towards well stimulation

Empyrean Energy Plc (LON:EME) told investors that gas production and sales has begun from the Dempsey well, in the Sacremento basin onshore California.

The well, which is 30% owned by Empyrean, is flowing gas at a rate of 140 thousand cubic feet of gas per day.

READ: Empyrean Energy hits main target in Dempsey well, more ‘significant’ gas shows

An application process is underway for the permitting of the enhanced reservoir stimulation of the well is proceeding as planned, and it expects stimulation operations expected in the first quarter of 2018.

Milestone

"This is a milestone achievement and with production and gas sales now underway at Dempsey 1-15 crucial data on the quality of the reservoir will now be collated ahead of fracture stimulating this zone,” said Tom Kelly, Empyrean chief executive.

“We have been informed by Sacgasco, the operator of the well, that the fracture stimulation planning and permitting has commenced in earnest and is proceeding smoothly with a view to commencing during the first quarter of 2018.

“I look forward to providing further updates as they become available."

Quick facts: Empyrean Energy PLC

Price: £0.10

Market: AIM
Market Cap: £43.93 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: CB2 Insights licenses electronic data capture software to UK...

CB2 Insights (CSE:CBII-OTCQB: CBIIF) CEO Prad Sekar joined Steve Darling from Proactive Vancouver to discuss the company doing a deal with MYACCESS Clinics. This will allow CB2’s software to capture comprehensive data sets related to patient health and treatment histories and manage ongoing...

15 hours, 16 minutes ago

2 min read